Huron Consulting Group Inc. (HURN) 10-Year Financial Performance & Capital Metrics

HURN • • Industrial / General

IndustrialsConsulting ServicesSpecialized Niche ConsultingHealthcare & Education Consultants

AboutHuron Consulting Group Inc., a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Business Advisory, and Education. The Healthcare segment provides advisory services in the areas of financial and operational improvement, care transformation, and revenue cycle managed services; organizational transformation; and digital, technology and analytic solutions to national and regional hospitals, integrated health systems, academic medical centers, community hospitals, medical groups, and health plans. The Business Advisory segment offers cloud-based technology, analytics, restructuring, and capital advisory solutions to life science, financial, healthcare, education, energy and utilities, and industrials and manufacturing industries, as well as to public sectors. The Education segment provides research enterprise and student lifecycle; digital, technology and analytic solutions; and organizational transformation services to public and private colleges and universities, academic medical centers, research institutes, and other not-for-profit organizations. Huron Consulting Group Inc. was incorporated in 2002 and is headquartered in Chicago, Illinois.Show more

Revenue $1.49B +9.1%
EBITDA $187M +29.7%
Net Income $117M +86.7%
EPS (Diluted) 6.27 +96.6%
Gross Margin 32.03% +4.0%
EBITDA Margin 12.55% +18.9%
Operating Margin 11.36% +23.4%
Net Margin 7.85% +71.1%
ROE 21.32% +85.1%
ROIC 13.82% +30.9%
Debt/Equity 0.71 +1.2%
Interest Coverage 6.66 +4.0%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y profit CAGR of 22.8%
✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 11.1%
✓Good 3Y average ROE of 15.4%
✓Share count reduced 5.0% through buybacks

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y9%

5Y11.13%

3Y17.95%

TTM13.29%

Profit (Net Income) CAGR

10Y3.97%

5Y22.81%

3Y22.8%

TTM26.8%

EPS CAGR

10Y6.16%

5Y27.65%

3Y29.46%

TTM29.78%

ROCE

10Y Avg5.46%

5Y Avg8.73%

3Y Avg13.66%

Latest17.19%

Peer Comparison

Healthcare & Education Consultants

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
HURNHuron Consulting Group Inc.	3.2B	185.58	29.60	9.11%	6.66%	21.68%	6.02%	0.71
SBCSBC Medical Group Holdings Incorporated	462.62M	4.51	9.34	6.13%	24.28%	17.47%	3.71%	0.06
SBCWWSBC Medical Group Holdings Incorporated		0.25	0.52	6.13%	24.28%	17.47%		0.06
RYOJrYojbaba Co., Ltd. Common Shares	37.46M	3.33		5.6%	11.51%	68.18%	1.82%	4.12

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	699.01M	726.27M	732.57M	795.13M	876.76M	844.13M	905.64M	1.13B	1.36B	1.49B
Revenue Growth %	0.11%	0.04%	0.01%	0.09%	0.1%	-0.04%	0.07%	0.25%	0.2%	0.09%
Cost of Goods Sold+	401.92M	437.56M	454.81M	521.54M	575.6M	592.43M	636.78M	785.88M	942.7M	1.01B
COGS % of Revenue	0.57%	0.6%	0.62%	0.66%	0.66%	0.7%	0.7%	0.69%	0.69%	0.68%
Gross Profit+	297.1M	288.72M	277.76M	273.59M	301.15M	251.7M	268.86M	346.57M	419.36M	476.01M
Gross Margin %	0.43%	0.4%	0.38%	0.34%	0.34%	0.3%	0.3%	0.31%	0.31%	0.32%
Gross Profit Growth %	0.22%	-0.03%	-0.04%	-0.02%	0.1%	-0.16%	0.07%	0.29%	0.21%	0.14%
Operating Expenses+	193.6M	214.48M	485.22M	221.49M	237.45M	280.55M	216.03M	246.81M	294.01M	307.19M
OpEx % of Revenue	0.28%	0.3%	0.66%	0.28%	0.27%	0.33%	0.24%	0.22%	0.22%	0.21%
Selling, General & Admin	156.7M	160.2M	173.66M	180.98M	200.39M	169.4M	176.3M	207.52M	253.57M	283.79M
SG&A % of Revenue	0.22%	0.22%	0.24%	0.23%	0.23%	0.2%	0.19%	0.18%	0.19%	0.19%
Research & Development	1M	1.1M	800K	1.4M	3M	4.7M	5.2M	5.9M	6.5M	7.6M
R&D % of Revenue	0%	0%	0%	0%	0%	0.01%	0.01%	0.01%	0%	0.01%
Other Operating Expenses	35.9M	53.18M	310.76M	39.11M	34.06M	106.45M	34.52M	33.39M	33.94M	15.79M
Operating Income+	103.5M	74.23M	-207.46M	52.1M	63.71M	-28.85M	52.84M	99.76M	125.35M	168.82M
Operating Margin %	0.15%	0.1%	-0.28%	0.07%	0.07%	-0.03%	0.06%	0.09%	0.09%	0.11%
Operating Income Growth %	0.17%	-0.28%	-3.79%	1.25%	0.22%	-1.45%	2.83%	0.89%	0.26%	0.35%
EBITDA+	144.58M	119.95M	-158.17M	90.01M	94.91M	-3.33M	73.62M	121.22M	143.79M	186.52M
EBITDA Margin %	0.21%	0.17%	-0.22%	0.11%	0.11%	-0%	0.08%	0.11%	0.11%	0.13%
EBITDA Growth %	0.23%	-0.17%	-2.32%	1.57%	0.05%	-1.04%	23.11%	0.65%	0.19%	0.3%
D&A (Non-Cash Add-back)	41.08M	45.72M	49.29M	37.91M	31.2M	25.52M	20.78M	21.46M	18.44M	17.7M
EBIT	98.53M	81.84M	54.69M	53.63M	67.05M	52.62M	67.02M	111.72M	141.25M	166.59M
Net Interest Income+	-18.14M	-16.27M	-18.61M	-19.01M	-15.65M	-9.29M	-8.15M	-11.88M	-19.57M	-25.35M
Interest Income	480K	242K	69K	0	0	0	0	0	0	0
Interest Expense	18.62M	16.52M	18.68M	19.01M	15.65M	9.29M	8.15M	11.88M	19.57M	25.35M
Other Income/Expense	-19.93M	-15.08M	-15.05M	-26.88M	-11.21M	-5.02M	27.2M	8.82M	-41.45M	-14.8M
Pretax Income+	83.56M	59.16M	-222.5M	25.22M	52.49M	-33.87M	80.04M	108.58M	83.89M	154.02M
Pretax Margin %	0.12%	0.08%	-0.3%	0.03%	0.06%	-0.04%	0.09%	0.1%	0.06%	0.1%
Income Tax+	21.67M	19.68M	-52M	11.28M	10.51M	-10.15M	17.05M	33.02M	21.42M	37.39M
Effective Tax Rate %	0.71%	0.64%	0.76%	0.54%	0.8%	0.7%	0.79%	0.7%	0.74%	0.76%
Net Income+	59.05M	37.62M	-170.12M	13.65M	41.74M	-23.72M	62.99M	75.55M	62.48M	116.63M
Net Margin %	0.08%	0.05%	-0.23%	0.02%	0.05%	-0.03%	0.07%	0.07%	0.05%	0.08%
Net Income Growth %	-0.25%	-0.36%	-5.52%	1.08%	2.06%	-1.57%	3.66%	0.2%	-0.17%	0.87%
Net Income (Continuing)	61.9M	39.48M	-170.5M	13.94M	41.98M	-23.72M	62.99M	75.55M	62.48M	116.63M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	2.61	1.76	-7.93	0.62	1.85	-1.08	2.89	3.64	3.19	6.27
EPS Growth %	-0.24%	-0.33%	-5.51%	1.08%	1.98%	-1.58%	3.68%	0.26%	-0.12%	0.97%
EPS (Basic)	2.67	1.78	-7.93	0.63	1.90	-1.08	2.94	3.73	3.32	6.52
Diluted Shares Outstanding	22.6M	21.42M	21.44M	22.06M	22.51M	21.88M	21.81M	20.75M	19.6M	18.61M
Basic Shares Outstanding	22.14M	21.08M	21.44M	21.71M	21.99M	21.88M	21.44M	20.25M	18.83M	17.89M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	229.59M	180.08M	191.29M	232.93M	224.74M	230.51M	257.68M	328.48M	400.46M	409.12M
Cash & Short-Term Investments	58.44M	17.03M	16.91M	33.11M	11.6M	67.18M	20.78M	11.83M	12.15M	21.91M
Cash Only	58.44M	17.03M	16.91M	33.11M	11.6M	67.18M	20.78M	11.83M	12.15M	21.91M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	142.23M	149.75M	163.44M	185.9M	198.88M	146.77M	221.67M	290.59M	359.82M	359.14M
Days Sales Outstanding	74.27	75.26	81.43	85.34	82.8	63.46	89.34	93.66	96.42	88.21
Inventory	0	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-
Other Current Assets	27.72M	13.31M	10.95M	13.92M	14.25M	0	15.23M	26.06M	28.49M	28.06M
Total Non-Current Assets+	931.16M	973.13M	845.63M	816.6M	879.53M	820.46M	861.67M	870.56M	861.68M	934.5M
Property, Plant & Equipment	28.89M	32.43M	45.54M	40.37M	93.37M	68.45M	66.31M	56.41M	47.86M	40.85M
Fixed Asset Turnover	24.20x	22.39x	16.09x	19.69x	9.39x	12.33x	13.66x	20.08x	28.46x	36.38x
Goodwill	751.4M	799.86M	645.75M	645.26M	646.68M	594.24M	620.88M	624.97M	625.71M	678.74M
Intangible Assets	94.99M	81.35M	72.31M	47.86M	31.63M	38.38M	49.89M	49.59M	63.57M	87.18M
Long-Term Investments	34.83M	34.67M	39.9M	50.43M	54.54M	71.03M	72.58M	96.33M	76.31M	71.09M
Other Non-Current Assets	21.05M	24.81M	25.38M	30.52M	52.18M	44.17M	50.19M	41.71M	45.95M	54.09M
Total Assets+	1.16B	1.15B	1.04B	1.05B	1.1B	1.05B	1.12B	1.2B	1.26B	1.34B
Asset Turnover	0.60x	0.63x	0.71x	0.76x	0.79x	0.80x	0.81x	0.94x	1.08x	1.11x
Asset Growth %	0.01%	-0.01%	-0.1%	0.01%	0.05%	-0.05%	0.07%	0.07%	0.05%	0.06%
Total Current Liabilities+	131.42M	135.77M	139.47M	418.31M	204.54M	186.87M	205.18M	245.68M	302.57M	338.82M
Accounts Payable	7.22M	7.27M	9.19M	10.02M	7.94M	648K	13.62M	14.25M	10.07M	11.54M
Days Payables Outstanding	6.56	6.07	7.38	7.01	5.04	0.4	7.81	6.62	3.9	4.17
Short-Term Debt	0	0	501K	243.13M	8M	9.27M	10.7M	10.53M	11.03M	26.07M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	24.28M	21.77M	28.16M	27.2M	18.55M	14.87M	22.52M	27.27M	33.09M	26.77M
Current Ratio	1.75x	1.33x	1.37x	0.56x	1.10x	1.23x	1.26x	1.34x	1.32x	1.21x
Quick Ratio	1.75x	1.33x	1.37x	0.56x	1.10x	1.23x	1.26x	1.34x	1.32x	1.21x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	375.8M	369.41M	394.14M	90.6M	353.55M	312.16M	342.26M	401.32M	426.68M	443.47M
Long-Term Debt	307.38M	292.06M	342.51M	53.85M	247.61M	202.78M	232.22M	290M	324M	342.86M
Capital Lease Obligations	0	0	0	0	69.23M	61.83M	54.31M	45.56M	38.85M	29.69M
Deferred Tax Liabilities	34.69M	35.63M	1.1M	732K	8.07M	428K	12.27M	32.15M	28.16M	28.45M
Other Non-Current Liabilities	33.73M	41.72M	35.21M	22.32M	28.64M	47.13M	43.46M	33.61M	35.66M	42.48M
Total Liabilities	507.22M	505.18M	533.61M	508.91M	558.09M	499.03M	547.45M	647M	729.25M	782.29M
Total Debt+	307.38M	292.06M	343.01M	296.99M	324.84M	273.88M	297.24M	346.09M	373.88M	398.61M
Net Debt	248.94M	275.04M	326.1M	263.88M	313.24M	206.7M	276.45M	334.25M	361.73M	376.7M
Debt / Equity	0.47x	0.45x	0.68x	0.55x	0.59x	0.50x	0.52x	0.63x	0.70x	0.71x
Debt / EBITDA	2.13x	2.43x	-	3.30x	3.42x	-	4.04x	2.86x	2.60x	2.14x
Net Debt / EBITDA	1.72x	2.29x	-	2.93x	3.30x	-	3.76x	2.76x	2.52x	2.02x
Interest Coverage	5.56x	4.49x	-11.10x	2.74x	4.07x	-3.11x	6.48x	8.40x	6.40x	6.66x
Total Equity+	652.33M	648.03M	503.32M	540.62M	546.18M	551.94M	571.9M	552.04M	532.89M	561.33M
Equity Growth %	0.09%	-0.01%	-0.22%	0.07%	0.01%	0.01%	0.04%	-0.03%	-0.03%	0.05%
Book Value per Share	28.86	30.25	23.48	24.51	24.27	25.22	26.22	26.61	27.19	30.16
Total Shareholders' Equity	652.33M	648.03M	503.32M	540.62M	546.18M	551.94M	571.9M	552.04M	532.89M	561.33M
Common Stock	241K	235K	241K	244K	247K	246K	239K	223K	212K	208K
Retained Earnings	313.87M	351.48M	180.44M	196.11M	237.85M	214.01M	277M	352.55M	415.03M	531.65M
Treasury Stock	-103.73M	-113.19M	-121.99M	-124.79M	-128.35M	-129.89M	-135.97M	-137.56M	-142.14M	-160.09M
Accumulated OCI	3.58M	3.62M	10.37M	16.5M	14.94M	13.06M	16.84M	18.12M	22.83M	11.89M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	164.27M	128.31M	99.8M	101.66M	132.22M	136.74M	17.99M	85.4M	135.26M	201.32M
Operating CF Margin %	0.23%	0.18%	0.14%	0.13%	0.15%	0.16%	0.02%	0.08%	0.1%	0.14%
Operating CF Growth %	0.12%	-0.22%	-0.22%	0.02%	0.3%	0.03%	-0.87%	3.75%	0.58%	0.49%
Net Income	59.05M	37.62M	-170.12M	13.65M	41.74M	-23.84M	62.99M	75.55M	62.48M	116.63M
Depreciation & Amortization	58.05M	46.82M	50.09M	39.31M	34.41M	30.22M	25.98M	27.36M	24.94M	25.3M
Stock-Based Compensation	21.49M	16.58M	14.84M	18.82M	24.21M	24.08M	25.86M	30.97M	45.7M	45.07M
Deferred Taxes	2.77M	257K	-53.75M	10.72M	8.79M	-9.86M	12.48M	18.78M	-6.18M	2.61M
Other Non-Cash Items	12.66M	11.87M	266.69M	17.16M	15.42M	82.55M	-25.3M	-20.54M	39.47M	8.79M
Working Capital Changes	10.25M	15.18M	-7.96M	2.01M	7.64M	33.58M	-84.02M	-46.73M	-31.14M	2.92M
Change in Receivables	-2.84M	1.44M	1.65M	-10.51M	-10.12M	33.05M	-39.84M	-25.85M	0	627K
Change in Inventory	-8.27M	17.39M	-15.66M	23.03M	19.93M	5.74M	-44.13M	0	0	0
Change in Payables	7.68M	-3.14M	3.73M	-8.21M	-6.88M	-7.79M	10.39M	-13.47M	-6.95M	-12.23M
Cash from Investing+	-272.16M	-86.64M	-128.95M	-18.56M	-35M	-42.03M	-20.14M	-20.13M	-36.65M	-79.75M
Capital Expenditures	-19.44M	-15.02M	-25.77M	-15.01M	-23.55M	-16.4M	-15.76M	-24.3M	-35.19M	-32.58M
CapEx % of Revenue	0.03%	0.02%	0.04%	0.02%	0.03%	0.02%	0.02%	0.02%	0.03%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	1.18M	1.04M	0	0	0	154K	154K	154K
Cash from Financing+	-89.95M	-83.16M	28.82M	-66.69M	-118.84M	-39.62M	-44.41M	-74.11M	-98.33M	-111.64M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	3.59M	1.05M	-3.09M	-6.62M	-3.43M	1M	804K	-3.14M	966K	-231K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	144.83M	113.29M	74.02M	86.65M	108.67M	120.34M	2.23M	61.1M	100.08M	192.67M
FCF Margin %	0.21%	0.16%	0.1%	0.11%	0.12%	0.14%	0%	0.05%	0.07%	0.13%
FCF Growth %	0.2%	-0.22%	-0.35%	0.17%	0.25%	0.11%	-0.98%	26.44%	0.64%	0.93%
FCF per Share	6.41	5.29	3.45	3.93	4.83	5.50	0.10	2.95	5.11	10.35
FCF Conversion (FCF/Net Income)	2.78x	3.41x	-0.59x	7.45x	3.17x	-5.77x	0.29x	1.13x	2.16x	1.73x
Interest Paid	9.27M	6.47M	9.07M	8.89M	7.97M	8.31M	7.98M	12.25M	27.01M	33.32M
Taxes Paid	10.96M	24.58M	5.4M	3.35M	1.43M	4.72M	8.45M	13.48M	33.85M	30.15M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	9.43%	5.79%	-29.55%	2.61%	7.68%	-4.32%	11.21%	13.44%	11.52%	21.32%
Return on Invested Capital (ROIC)	9.69%	6.1%	-17.76%	4.78%	5.74%	-2.67%	4.93%	8.63%	10.56%	13.82%
Gross Margin	42.5%	39.75%	37.92%	34.41%	34.35%	29.82%	29.69%	30.6%	30.79%	32.03%
Net Margin	8.45%	5.18%	-23.22%	1.72%	4.76%	-2.81%	6.96%	6.67%	4.59%	7.85%
Debt / Equity	0.47x	0.45x	0.68x	0.55x	0.59x	0.50x	0.52x	0.63x	0.70x	0.71x
Interest Coverage	5.56x	4.49x	-11.10x	2.74x	4.07x	-3.11x	6.48x	8.40x	6.40x	6.66x
FCF Conversion	2.78x	3.41x	-0.59x	7.45x	3.17x	-5.77x	0.29x	1.13x	2.16x	1.73x
Revenue Growth	11.36%	3.9%	0.87%	8.54%	10.27%	-3.72%	7.29%	25.04%	20.28%	9.11%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Healthcare	-	-	-	-	-	98.84M	47.72M	535M	673.99M	777.44M
Healthcare Growth	-	-	-	-	-	-	-51.72%	1021.17%	25.98%	15.35%
Education	-	-	167.91M	23.68M	29.18M	31.86M	39.18M	359.83M	429.66M	483.54M
Education Growth	-	-	-	-85.90%	23.24%	9.18%	22.96%	818.44%	19.41%	12.54%
Commercial	-	-	-	-	-	-	-	237.62M	258.41M	260.83M
Commercial Growth	-	-	-	-	-	-	-	-	8.75%	0.94%
Business Advisory	-	122.38M	207.75M	10.85M	9.16M	13.61M	-	-	-	-
Business Advisory Growth	-	-	69.76%	-94.78%	-15.59%	48.66%	-	-	-	-
Health Care	446.89M	424.91M	356.91M	117.35M	118.31M	-	-	-	-	-
Health Care Growth	-	-4.92%	-16.00%	-67.12%	0.82%	-	-	-	-	-
Others	1.22M	-	-	-	-	-	-	-	-	-
Others Growth	-	-	-	-	-	-	-	-	-	-
Education And Life Sciences	167.93M	178.98M	-	-	-	-	-	-	-	-
Education And Life Sciences Growth	-	6.58%	-	-	-	-	-	-	-	-
Huron Business Advisory	82.97M	-	-	-	-	-	-	-	-	-
Huron Business Advisory Growth	-	-	-	-	-	-	-	-	-	-

Frequently Asked Questions

Valuation & Price

Huron Consulting Group Inc. (HURN) has a price-to-earnings (P/E) ratio of 29.6x. This suggests investors expect higher future growth.

Growth & Financials

Huron Consulting Group Inc. (HURN) reported $1.63B in revenue for fiscal year 2024. This represents a 147% increase from $657.9M in 2011.

Huron Consulting Group Inc. (HURN) grew revenue by 9.1% over the past year. This is steady growth.

Yes, Huron Consulting Group Inc. (HURN) is profitable, generating $108.4M in net income for fiscal year 2024 (7.8% net margin).

Dividend & Returns

Huron Consulting Group Inc. (HURN) has a return on equity (ROE) of 21.3%. This is excellent, indicating efficient use of shareholder capital.

Huron Consulting Group Inc. (HURN) generated $191.5M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...